Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Short term Debt: 2013-2025

Historic Short term Debt for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $923,000.

  • Amphastar Pharmaceuticals' Short term Debt rose 266.27% to $923,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $923,000, marking a year-over-year increase of 266.27%. This contributed to the annual value of $234,000 for FY2024, which is 46.33% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Short term Debt is $923,000, which was down 0.43% from $927,000 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Short term Debt ranged from a high of $12.9 million in Q2 2023 and a low of $224,000 during Q1 2025.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Short term Debt value was $433,000 (recorded in 2023), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Short term Debt surged by 528.10% in 2023, and later plummeted by 98.07% in 2024.
  • Amphastar Pharmaceuticals' Short term Debt (Quarterly) stood at $2.2 million in 2021, then skyrocketed by 38.33% to $3.0 million in 2022, then crashed by 85.69% to $436,000 in 2023, then tumbled by 46.33% to $234,000 in 2024, then skyrocketed by 266.27% to $923,000 in 2025.
  • Its Short term Debt was $923,000 in Q3 2025, compared to $927,000 in Q2 2025 and $224,000 in Q1 2025.